1. Home
  2. RDY vs DEI Comparison

RDY vs DEI Comparison

Compare RDY & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • DEI
  • Stock Information
  • Founded
  • RDY 1984
  • DEI 1971
  • Country
  • RDY India
  • DEI United States
  • Employees
  • RDY N/A
  • DEI N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • DEI Real Estate Investment Trusts
  • Sector
  • RDY Health Care
  • DEI Real Estate
  • Exchange
  • RDY Nasdaq
  • DEI Nasdaq
  • Market Cap
  • RDY 2.1B
  • DEI 2.4B
  • IPO Year
  • RDY N/A
  • DEI 2006
  • Fundamental
  • Price
  • RDY $15.23
  • DEI $14.87
  • Analyst Decision
  • RDY Strong Buy
  • DEI Buy
  • Analyst Count
  • RDY 2
  • DEI 9
  • Target Price
  • RDY $16.95
  • DEI $18.13
  • AVG Volume (30 Days)
  • RDY 1.7M
  • DEI 1.6M
  • Earning Date
  • RDY 07-28-2025
  • DEI 08-07-2025
  • Dividend Yield
  • RDY 0.63%
  • DEI 5.10%
  • EPS Growth
  • RDY 1.47
  • DEI N/A
  • EPS
  • RDY 0.79
  • DEI 0.32
  • Revenue
  • RDY $3,809,801,863.00
  • DEI $995,663,000.00
  • Revenue This Year
  • RDY $10.24
  • DEI $1.10
  • Revenue Next Year
  • RDY N/A
  • DEI $2.30
  • P/E Ratio
  • RDY $19.24
  • DEI $46.67
  • Revenue Growth
  • RDY 16.61
  • DEI 1.93
  • 52 Week Low
  • RDY $12.26
  • DEI $12.39
  • 52 Week High
  • RDY $16.89
  • DEI $20.50
  • Technical
  • Relative Strength Index (RSI)
  • RDY 55.04
  • DEI 54.15
  • Support Level
  • RDY $15.16
  • DEI $14.70
  • Resistance Level
  • RDY $16.17
  • DEI $15.20
  • Average True Range (ATR)
  • RDY 0.20
  • DEI 0.36
  • MACD
  • RDY -0.07
  • DEI 0.03
  • Stochastic Oscillator
  • RDY 39.74
  • DEI 64.71

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.

Share on Social Networks: